Characterization of prostaglandin E2 receptors and their role in 24,25-(OH)2D3-mediated effects on resting zone chondrocytes

被引:0
|
作者
Del Toro, F
Sylvia, VL
Schubkegel, SR
Campos, R
Dean, DD
Boyan, BD
Schwartz, Z
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Orthopaed, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Orthodont, San Antonio, TX 78284 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Periodont, San Antonio, TX 78284 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
[5] Wilford Hall USAF Med Ctr, Dept Periodont, San Antonio, TX 78236 USA
[6] Hebrew Univ Jerusalem, Jerusalem, Israel
关键词
D O I
10.1002/(SICI)1097-4652(200002)182:2<196::AID-JCP8>3.0.CO;2-E
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Resting zone chondrocyte differentiation is modulated by the vitamin D meabolite, 24,25-(OH)(2)D-3, via activation of protein kinase C (PKC). In previous studies, inhibition of prostaglandin production with indomethacin caused an increase in PKC activity, suggesting that changes in prostaglandin levels may mediate the 24,25-(OH)(2)D-3-dependent response and act as autocrine or paracrine regulators of chandrocyte metabolism. Supporting this hypothesis is the fact that resting zone cells respond directly to prostaglandin E-2 (PCE2). The aim of the present study was to identify which PGE, receptor subtypes (EP) mediate the effects of PGE, on resting zone cells. Using primers specific for EP1-EP4, reverse transcription-polymerase chain reaction (RT-PCR) amplified EP1 and EP2 cDNA in a RT-dependent manner. A variant form of the EP1 cDNA, EPIv, was also amplified in an RT-dependent manner. In parallel experiments, we used EP subtype-specific agonists to examine the role of EP receptors in 24,25-(OH),D,mediated cell proliferation and differentiation. 17-phenyl-trinor-PGE(2) (PTPGE(2)), an EP1 agonist, increased [H-3]-thymidine incorporation in a dose-dependent manner and reversed the 24,25-(OH)(2)D-2-induced inhibition of [H-3]-thymidine incorporation. SC-19220, an EP1 antagonist, caused a further dose-dependent decrease in 24,25-(OH)(2)D-2-induced inhibition of [H-3]-thymidine incorporation. PTPGE(2) also caused a biphasic increase in [S-35]-sulfate incorporation and increased alkaline phosphatase enzyme activity at high concentrations (10(-8) M). 24,25-(OH)(2)D-3-induced alkaline phosphatase activity was synergistically stimulated in a dose-dependent manner by PTPGE(2). In contrast, 24,25-(OH)(2)D-3 induced PKC activity was inhibited in a dose-dependent manner by PTPGE, and SC-1 9220, the EP1 antagonist, elevated PKC activity at high concentrations (10-8 M). The EP2 agonist, misoprostol, only affected [S-35]-sulfate incorporation, but in a dose-dependent manner. The EP3 and EP4 agonists had no effect on cell response. These results suggest that the EP1 receptor subtype mediates some of the PGE(2)-induced cellular responses in resting zone cells that lead to both increased proliferation and differentiation. Because 24,25-(OH)(2)D-3 inhibits PGE(2) synthesis in these cells, EP1-mediated induction of proliferation is blocked, encouraging cellular maturation and activation of PKC activity. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:196 / 208
页数:13
相关论文
共 50 条
  • [1] Regulation of resting zone chondrocytes by 24,25-(OH)(2)D-3 is mediated by diacylglycerol and protein kinase C
    Helm, S
    Sylvia, V
    Kimbel, K
    Gomez, R
    Dean, DD
    Schwartz, Z
    Boyan, BD
    JOURNAL OF DENTAL RESEARCH, 1996, 75 : 2671 - 2671
  • [2] TREATMENT OF RESTING ZONE CHONDROCYTES WITH 24,25-(OH)2D(3)CHANGES THEIR STAGE OF MATURATION
    SCHWARTZ, Z
    DEAN, D
    GOMEZ, R
    SCHEELE, S
    RESPONDEK, M
    BOYAN, BD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S213 - S213
  • [3] 24,25-(OH)2D3 INDUCES MATURATION OF RESTING ZONE CHONDROCYTES IN-VITRO
    WALTON, JK
    SCHWARTZ, Z
    RESPONDEK, M
    DEAN, DD
    LUNA, MH
    BROOKS, BP
    BOYAN, BD
    JOURNAL OF DENTAL RESEARCH, 1994, 73 : 315 - 315
  • [4] TREATMENT OF RESTING ZONE CHONDROCYTES WITH 24,25-DIHYDROXYVITAMIN D-3[24,25-(OH)(2)D-3] INDUCES DIFFERENTIATION INTO A 1,25-(OH)(2)D-3-RESPONSIVE PHENOTYPE CHARACTERISTIC OF GROWTH ZONE CHONDROCYTES
    SCHWARTZ, Z
    DEAN, DD
    WALTON, JK
    BROOKS, BP
    BOYAN, BD
    ENDOCRINOLOGY, 1995, 136 (02) : 402 - 411
  • [5] CONVERSION OF 25-(OH)D3 TO 24,25-(OH)2D3 AND NUCLEAR BINDING OF 24,25-(OH)2D3 IN CHONDROCYTES
    CORVOL, MT
    DUMONTIER, MF
    GARABEDIAN, M
    RAPPAPORT, R
    PEDIATRIC RESEARCH, 1978, 12 (11) : 1094 - 1094
  • [6] MECHANISM OF PROTEIN-KINASE-C ACTIVATION BY 24,25-(OH)2D3 IN RESTING ZONE CHONDROCYTES
    SYLVIA, V
    HELM, JS
    DEAN, DD
    LU, Y
    SCHWARTZ, Z
    BOYAN, BD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S395 - S395
  • [7] Chondrocytes have membrane receptors specific for 1,25-(OH)2D3 and 24,25-(OH)2D3.
    Boyan, BD
    Pedrozo, HA
    Rimes, S
    Sylvia, VL
    Nemere, I
    Posner, GH
    Dean, DD
    Schwartz, Z
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S301 - S301
  • [8] The synergistic effect of TGF beta and 24,25-(OH)(2)D-3 on resting zone chondrocytes is metabolite-specific and mediated by PKC
    Schwartz, Z
    Sylvia, VL
    Dean, DD
    Boyan, BD
    CONNECTIVE TISSUE RESEARCH, 1996, 35 (1-4) : 101 - 106
  • [9] REGULATION OF ARACHIDONIC-ACID TURNOVER BY 1,25-(OH)2D3 AND 24,25-(OH)2D3 IN GROWTH ZONE AND RESTING ZONE CHONDROCYTE CULTURES
    SCHWARTZ, Z
    SWAIN, LD
    RAMIREZ, V
    BOYAN, BD
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) : 278 - 286
  • [10] Treatment of resting zone chondrocytes with transforming growth factor-β1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3
    Schwartz, Z
    Sylvia, VL
    Liu, Y
    Dean, DD
    Boyan, BD
    BONE, 1998, 23 (05) : 465 - 470